The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Abstract
The use of danazol (Danocrine) appears to be the most effective medical form of therapy for endometriosis. A double-blind study on 32 patients with laparoscopically proved pelvic endometriosis was designed to evaluate the immediate short-term and long-term effectiveness of daily dosages of danazol (100, 200, 400, and 600 mg) on the amelioration of the disease, with the use of posttreatment surgical findings and symptomatic changes. The American Fertility Society classification based on a point system was used. The clinical and surgical improvement rates varied from 75% to 85% and 50% to 70%, respectively. Ovarian endometriomas of even 1 cm in size generally do not respond to danazol. The pregnancy rate was 45%. We have demonstrated that lower than maximum doses of danazol produce similar beneficial effects in the treatment. With the low dosages, we did not achieve freedom from side-effects. The average symptomatic recurrence rate was 36%, with a mean duration of 19 months of follow-up, and was dose dependent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This treatment was effective in reducing pain among about 90% of the women with endometriosis.92”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [92]
In the citing paper
“For additional endpoints, findings similar to the VAS score were obtained with other indices for pain symptoms, such as the Biberoglu and Behrman (B&B) scale [118].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [118]
In the citing paper
“Mean percentage hot flushes in the relugolix CT and delayed relugolix CT groups at week 24 were 10.4% and 33.6% in SPIRIT-1 and 13.6% and 35% in SPIRIT-2 [118,119].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [118]
Citations
Cites
Classification of Endometriosis
(1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44409-2 · Cited by 304
Goldfarb, A. F. (1970) · Fertility and Sterility · doi:10.1016/s0015-0282(16)37275-2 · Cited by 279
Clinical Studies with an Antigonadotropin-Danazol
Greenblatt, R. B., Dmowski, W. P., Mahesh, V. B., & Scholer, H. F. L. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)38045-1 · Cited by 219
Antigonadotropin (danazol) in the treatment of endometriosis
Dmowski, W. P., & Cohen, M. R. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90436-2 · Cited by 130
Danazol Inhibits Steroidogenesis
Barbieri, R. L., Canick, J. A., Makris, A., Todd, R. B., DAVIES, I. J., & Ryan, K. J. (1977) · Fertility and Sterility · doi:10.1016/s0015-0282(16)42732-9 · Cited by 124
Management of Endometriosis in the Infertile Patient
Kistner, R. W. (1975) · Fertility and Sterility · doi:10.1016/s0015-0282(16)41528-1 · Cited by 123
Dmowski, W. P., & Mr, C. (1975) · PubMed · Cited by 105
Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties
Dmowski, W. P., Scholer, H. F. L., Mahesh, V. B., & Greenblatt, R. B. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)37981-x · Cited by 96
Pituitary Gonadotropin Inhibitory Activity of Danazol
POTTS, G. O., BEYLER, A. L., & Schane, H. P. (1974) · Fertility and Sterility · doi:10.1016/s0015-0282(16)40338-9 · Cited by 76
Endometriosis: Treatment with hormonal pseudopregnancy and/or operation
Andrews, W. C., & Larsen, G. (1974) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33739-5 · Cited by 75
Cited by
Vercellini, P., Fedele, L., Aimi, G., Pietropaolo, G., Consonni, D., & Crosignani, P. G. (2007) · Human Reproduction · doi:10.1093/humrep/del339 · Cited by 547
Endometriosis and pelvic pain: relation to disease stage and localization
Vercellini, P., Trespidi, L., De Giorgi, O., Cortesi, I., Parazzini, F., & Crosignani, P. G. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58089-3 · Cited by 457
Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications
Stratton, P., & Berkley, K. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq050 · Cited by 442
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
Treatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Metadata
- Authors
- Biberoglu, K. O., & Behrman, S. J.
- Affiliations
- Beaumont Health (US)
- Corresponding author
- Biberoglu, K.O.
- ORCID
- Biberoglu, K.O.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 1981-03
- Volume
- 139
- Issue
- 6
- Pages
- 645-654
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W1876522572
- Cited by
- 267
- References
- 25
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 3 · 2021: 10 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 8 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 6 · 2012: 12
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- danazol, endometriosis, dosage, dose-response relationship, endometrioma, recurrence, pregnancy rate, intraoperative findings, American Fertility Society classification, medical therapy
- MeSH terms
- Adult, Body Weight, Danazol, Double-Blind Method, Endometriosis, Female, Follow-Up Studies, Humans, Menstruation, Pelvic Neoplasms, Laparoscopy, Pregnadienes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness. https://app.cochat.ai/papers/10.1016/0002-9378(81)90478-6
- The paper
- Biberoglu, K. O., & Behrman, S. J. (1981). Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/0002-9378(81)90478-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.